These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32946418)

  • 21. Instrumental variable methods for causal inference.
    Baiocchi M; Cheng J; Small DS
    Stat Med; 2014 Jun; 33(13):2297-340. PubMed ID: 24599889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.
    McGuinness MB; Kasza J; Karahalios A; Guymer RH; Finger RP; Simpson JA
    BMC Med Res Methodol; 2019 Dec; 19(1):223. PubMed ID: 31795945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases.
    Benasseur I; Talbot D; Durand M; Holbrook A; Matteau A; Potter BJ; Renoux C; Schnitzer ME; Tarride JÉ; Guertin JR
    Pharmacoepidemiol Drug Saf; 2022 Apr; 31(4):424-433. PubMed ID: 34953160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity analysis for unmeasured confounding in a marginal structural Cox proportional hazards model.
    Klungsøyr O; Sexton J; Sandanger I; Nygård JF
    Lifetime Data Anal; 2009 Jun; 15(2):278-94. PubMed ID: 19109770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Instrumental variable estimation in semi-parametric additive hazards models.
    Brueckner M; Titman A; Jaki T
    Biometrics; 2019 Mar; 75(1):110-120. PubMed ID: 30073669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Confounder adjustment in observational comparative effectiveness researches: (2) statistical adjustment approaches for unmeasured confounders].
    Huang LL; Wei YY; Chen F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1450-1455. PubMed ID: 31838820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
    Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
    BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the impact of unmeasured confounding for binary outcomes using confounding functions.
    Kasza J; Wolfe R; Schuster T
    Int J Epidemiol; 2017 Aug; 46(4):1303-1311. PubMed ID: 28338913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time dependent hazard ratio estimation using instrumental variables without conditioning on an omitted covariate.
    MacKenzie TA; Martinez-Camblor P; O'Malley AJ
    BMC Med Res Methodol; 2021 Mar; 21(1):56. PubMed ID: 33743583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing causal effects in observational survival data using propensity score matching design.
    Lu B; Cai D; Tong X
    Stat Med; 2018 May; 37(11):1846-1858. PubMed ID: 29399833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
    McCandless LC; Somers JM
    Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing the performance of two-stage residual inclusion methods when using physician's prescribing preference as an instrumental variable: unmeasured confounding and noncollapsibility.
    Zhang L; Lewsey J
    J Comp Eff Res; 2024 May; 13(5):e230085. PubMed ID: 38567965
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjusting for indirectly measured confounding using large-scale propensity score.
    Zhang L; Wang Y; Schuemie MJ; Blei DM; Hripcsak G
    J Biomed Inform; 2022 Oct; 134():104204. PubMed ID: 36108816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjusting for unmeasured confounding using validation data: Simplified two-stage calibration for survival and dichotomous outcomes.
    Hjellvik V; De Bruin ML; Samuelsen SO; Karlstad Ø; Andersen M; Haukka J; Vestergaard P; de Vries F; Furu K
    Stat Med; 2019 Jul; 38(15):2719-2734. PubMed ID: 30828842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Instrumental variable approach for estimating a causal hazard ratio: application to the effect of postmastectomy radiotherapy on breast cancer patients.
    Yang F; Cheng J; Huo D
    Obs Stud; 2019; 5():141-162. PubMed ID: 34223564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity analysis for the effects of multiple unmeasured confounders.
    Groenwold RH; Sterne JA; Lawlor DA; Moons KG; Hoes AW; Tilling K
    Ann Epidemiol; 2016 Sep; 26(9):605-11. PubMed ID: 27576907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review.
    Streeter AJ; Lin NX; Crathorne L; Haasova M; Hyde C; Melzer D; Henley WE
    J Clin Epidemiol; 2017 Jul; 87():23-34. PubMed ID: 28460857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study.
    Ren J; Cislo P; Cappelleri JC; Hlavacek P; DiBonaventura M
    BMC Med Res Methodol; 2023 Jan; 23(1):18. PubMed ID: 36647031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robust Machine Learning for Treatment Effects in Multilevel Observational Studies Under Cluster-level Unmeasured Confounding.
    Suk Y; Kang H
    Psychometrika; 2022 Mar; 87(1):310-343. PubMed ID: 34652613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.
    Karim ME; Petkau J; Gustafson P; Platt RW; Tremlett H;
    Stat Methods Med Res; 2018 Jun; 27(6):1709-1722. PubMed ID: 27659168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.